Work Package 7
Utilization
The Utilization WP provides the infrastructure for knowledge utilization, so that research outcomes can be translated into applications for society in domains such as education, health, and new media.
Examples of possible value creation are:
- Dissemination of scientific knowledge to the general public
- Mobile apps with commercial or social value
- Serious games such as for e-learning, coaching or therapy
- Software applications for patients
- Release of open source software
- Creation of IP as a basis for development of products in industry
- Validation of scientific knowledge for clinical settings, such as patient tests
- Development of standards or protocols
To enable this, WP7 will explore and participate in promising research lines in language research that can be applied in clinical or technological settings.
Current (PhD) research projects where WP7 is involved in are:
- Feedback loops in learning to perceive and produce non-native speech contrasts (a collaboration with WP1)
- Basal ganglia thalamocortical mechanisms of cognitive control in speaking (a collaboration with WP4)
- Data driven investigation of intrinsic dynamic brainstates underlying language processing (a collaboration with WP6)
Further, WP7 will develop showcase utilization projects. Also, it will take a leading role in providing support to all researchers in the consortium to help them to transform ideas, theories and inventions into products with commercial or social value, to coach them in identifying and designing applications, and to assist them in finding their way in the world of starting spin-offs, finding partners, and grant applications.
WP7 explores the creation of a variety of tools and resources, such as shaping a research infrastructure for language data and tools, setting up support for development of apps for mobile devices, setting up provisions for cloud computing facilities, or building expertise in business development, intellectual property (IP), product design, (scientific) programming, electronics, clinical protocols, and marketing.
People involved
WP-leaders
Antal van den Bosch (RU)
Peter Desain (RU)
Principal Investigators
Bas Bloem (RadboudUMC)